Download Citation
Article Source:
Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis
Shields SD,
Butt RP,
Dib-Hajj SD,
Waxman SG
(2015)
Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis.
PLOS ONE 10(3): e0119067.
https://doi.org/10.1371/journal.pone.0119067